Rock Springs Capital Management LP Travere Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $3.22 Billion
- Q2 2024
A detailed history of Rock Springs Capital Management LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 4,482,265 shares of TVTX stock, worth $60.4 Million. This represents 1.14% of its overall portfolio holdings.
Number of Shares
4,482,265
Previous 3,424,818
30.88%
Holding current value
$60.4 Million
Previous $26.4 Million
39.53%
% of portfolio
1.14%
Previous 0.69%
Shares
11 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.8MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$103 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$101 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$99.3 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$89.2 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.37MShares$58.9 Million0.04% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $865M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...